‘Significant step’ made in creating breakthrough blood test to detect brain tumours - A new blood test is being developed by ...
At present, diagnosing and treating patients can be complex ...
Presented updated glioblastoma (“GBM”) data demonstrating durable survival and a favorable safety profile across Phase 1 and Phase 2 programs, with repeat dosing of DeltEx™ Drug-Resistant ...
SCIENTISTS have made major progress on a blood test to detect brain tumours and monitor them in real time. The test is ...
Honing in on four markers for effective, patient-specific devices to combat glioblastoma.
Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, 'Telix”) today announces the resubmission of a New Drug Application ...
Researchers in China have developed magnetically controlled microrobots made from diatoms for the treatment of glioblastoma using photodynamic therapy. These microrobots exhibit excellent magnetic ...
NEW YORK, NY; NEW HAVEN, CT; and PRINCETON, NJ, March 10, 2026 (GLOBE NEWSWIRE) -- Aptorum Group Limited (NASDAQ: APM) ("Aptorum Group” or “Aptorum”), a clinical stage biopharmaceutical company ...
Lon Andrew Piddington recalls his mother's diagnosis and determination after being diagnosed with glioblastoma. He will run the ...
Market weakness is overshadowing this news. The post Telix shares drop despite promising US FDA update appeared first on The Motley Fool Australia.
The blood–brain barrier functions as an evolutionarily optimized vascular “filter,” permitting limited penetration of small molecules like temozolomide while effectively excluding most biologics from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results